Douglas Cole

Douglas Cole

DirectoratFoghorn Therapeutics· In proxies 2024–2025

Douglas Cole sits on 4 public boards.

Experience

  1. Foghorn TherapeuticsPublic company · 2 yr
    • Director2024 – Present · 2 yrStock in role -68%
  2. Sana BiotechnologyPublic company
    • Director? – PresentNo stock prices for these years
  3. Denali TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  4. Sigilon TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  5. Sana Biotechnology andPublic company · 8 yr
    • Director2015 – 2023 · 8 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?